BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10181410)

  • 1. PSO notice to providers: Uncle Sam wants you.
    Manag Care Strateg; 1998 Jun; 6(6):61-3. PubMed ID: 10181410
    [No Abstract]   [Full Text] [Related]  

  • 2. Does your PSO have what it takes to direct-contract?
    Public Sect Contract Rep; 1997 Sep; 3(9):129-33. PubMed ID: 10174882
    [No Abstract]   [Full Text] [Related]  

  • 3. PSO solvency standards application issued by HCFA.
    Public Sect Contract Rep; 1998 Apr; 4(4):63. PubMed ID: 10179401
    [No Abstract]   [Full Text] [Related]  

  • 4. Don't miss out on Medicare managed care.
    Terry K
    Med Econ; 1997 Apr; 74(7):58-60, 63, 68-70 passim. PubMed ID: 10165907
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicare's capitation rates are key to PSO profitability.
    Med Netw Strategy Rep; 1998 Mar; 7(3):7-8. PubMed ID: 10181280
    [No Abstract]   [Full Text] [Related]  

  • 6. Provider sponsored organizations: opportunity or regulatory quagmire?
    Krasner WL
    Manag Care Q; 1997; 5(4):65-8. PubMed ID: 10175723
    [No Abstract]   [Full Text] [Related]  

  • 7. Is your organization strategically prepared to be a Medicare PSO?
    Kelly M
    Healthc Financ Manage; 1998 May; 52(5):43-5. PubMed ID: 10179438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will Medicare provider-sponsored organizations be worth the risk?
    Larkin HD
    Med Netw Strategy Rep; 1998 Mar; 7(3):1-3. PubMed ID: 10181276
    [No Abstract]   [Full Text] [Related]  

  • 9. Exit from Medicare. Intermountain, PacifiCare drop risk plans in Utah.
    Shinkman R
    Mod Healthc; 1998 Jun; 28(25):10. PubMed ID: 10180947
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicare capitation: how much risk should you take?
    Terry K
    Med Econ; 1996 Mar; 73(5):45-6, 49-50, 52 passim. PubMed ID: 10156685
    [No Abstract]   [Full Text] [Related]  

  • 11. Providers could find pot of gold by pursuing the right Medicare contracting alternative.
    Public Sect Contract Rep; 1998 Mar; 4(3):41-5. PubMed ID: 10177851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When you look in your crystal ball, do you see a PSO in your future?
    Manag Care Strateg; 1998 May; 6(5):49-51. PubMed ID: 10181767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSO accord reached. Rules seek exclusion of weaker organizations.
    Weissenstein E
    Mod Healthc; 1998 Mar; 28(10):2, 6. PubMed ID: 10177175
    [No Abstract]   [Full Text] [Related]  

  • 14. Foundation takes 'go-slow' approach in global cap contracts in Northeast.
    Galdabini G
    Exec Solut Healthc Manag; 1999 Feb; 2(2):16-7. PubMed ID: 10346221
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicare PSOs. Task force recommends flexibility for provider-sponsored organizations.
    Med Netw Strategy Rep; 1998 Apr; 7(4):9-10. PubMed ID: 10181286
    [No Abstract]   [Full Text] [Related]  

  • 16. Network cuts cataract surgeries, boosts provider reimbursement.
    Public Sect Contract Rep; 1999 Aug; 5(8):116. PubMed ID: 10621108
    [No Abstract]   [Full Text] [Related]  

  • 17. HCFA readies for PSO solvency debate.
    Weissenstein E
    Mod Healthc; 1997 Sep; 27(35):6. PubMed ID: 10170385
    [No Abstract]   [Full Text] [Related]  

  • 18. Gaining enough market share may be a PSO's biggest challenge.
    Med Netw Strategy Rep; 1998 Mar; 7(3):8-10. PubMed ID: 10181281
    [No Abstract]   [Full Text] [Related]  

  • 19. What's a PSO? HCFA previews its definition.
    Weissenstein E
    Mod Healthc; 1998 Jan; 28(2):4. PubMed ID: 10175909
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk-based managed care contracting.
    Arpin D; Reeves R
    Med Netw Strategy Rep; 1997 Aug; 6(8):6-8. PubMed ID: 10170011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.